These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33889250)

  • 1. Estimate cost of providing methadone maintenance treatment at a methadone clinic in Nairobi Kenya: direct costs.
    Mogaka B; Kiburi SK; Mutinda M; Kendagor M
    Pan Afr Med J; 2021; 38():84. PubMed ID: 33889250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost of providing methadone maintenance treatment in Ontario, Canada.
    Zaric GS; Brennan AW; Varenbut M; Daiter JM
    Am J Drug Alcohol Abuse; 2012 Nov; 38(6):559-66. PubMed ID: 22783917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of provision of opioid substitution therapy provision in Tijuana, Mexico.
    Burgos JL; Cepeda JA; Kahn JG; Mittal ML; Meza E; Lazos RRP; Vargas PC; Vickerman P; Strathdee SA; Martin NK
    Harm Reduct J; 2018 May; 15(1):28. PubMed ID: 29792191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J; Barton G; Maskrey V; Pinto H; Holland R
    Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic costs of jail-based methadone maintenance treatment.
    Horn BP; Li X; Mamun S; McCrady B; French MT
    Am J Drug Alcohol Abuse; 2018; 44(6):611-618. PubMed ID: 30024783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.
    Bansback N; Guh D; Oviedo-Joekes E; Brissette S; Harrison S; Janmohamed A; Krausz M; MacDonald S; Marsh DC; Schechter MT; Anis AH
    Addiction; 2018 Jul; 113(7):1264-1273. PubMed ID: 29589873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Office-Based Buprenorphine Versus Clinic-Based Methadone: A Cost-Effectiveness Analysis.
    King JB; Sainski-Nguyen AM; Bellows BK
    J Pain Palliat Care Pharmacother; 2016; 30(1):55-65. PubMed ID: 27007583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-engineering methadone-Cost-effectiveness analysis of a patient-centered approach to methadone treatment.
    Dunlap LJ; Zarkin GA; Orme S; Meinhofer A; Kelly SM; O'Grady KE; Gryczynski J; Mitchell SG; Schwartz RP
    J Subst Abuse Treat; 2018 Nov; 94():81-90. PubMed ID: 30243422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail.
    Zarkin GA; Orme S; Dunlap LJ; Kelly SM; Mitchell SG; O'Grady KE; Schwartz RP
    Drug Alcohol Depend; 2020 Dec; 217():108292. PubMed ID: 32992151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment.
    Reimer J; Vogelmann T; Trümper D; Scherbaum N
    Subst Abuse Treat Prev Policy; 2019 Dec; 14(1):57. PubMed ID: 31842942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsidising patient dispensing fees: the cost of injecting equity into the opioid pharmacotherapy maintenance system.
    Chalmers J; Ritter A
    Drug Alcohol Rev; 2012 Nov; 31(7):911-7. PubMed ID: 22624529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.
    Byford S; Barrett B; Metrebian N; Groshkova T; Cary M; Charles V; Lintzeris N; Strang J
    Br J Psychiatry; 2013 Nov; 203(5):341-9. PubMed ID: 24029536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment.
    Nosyk B; Guh DP; Bansback NJ; Oviedo-Joekes E; Brissette S; Marsh DC; Meikleham E; Schechter MT; Anis AH
    CMAJ; 2012 Apr; 184(6):E317-28. PubMed ID: 22410375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
    Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
    Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
    Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
    J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone maintenance and the cost and utilization of health care among individuals dependent on opioids in a commercial health plan.
    McCarty D; Perrin NA; Green CA; Polen MR; Leo MC; Lynch F
    Drug Alcohol Depend; 2010 Oct; 111(3):235-40. PubMed ID: 20627427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of methadone therapy for opioid use disorder in Russia - a modeled cost-effectiveness analysis.
    Idrisov B; Murphy SM; Morrill T; Saadoun M; Lunze K; Shepard D
    Subst Abuse Treat Prev Policy; 2017 Jan; 12(1):4. PubMed ID: 28107824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.
    Avants SK; Margolin A; Sindelar JL; Rounsaville BJ; Schottenfeld R; Stine S; Cooney NL; Rosenheck RA; Li SH; Kosten TR
    Am J Psychiatry; 1999 Jan; 156(1):27-33. PubMed ID: 9892294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the experiences of clients receiving opioid use disorder treatment at a methadone clinic in Kenya: a qualitative study.
    Kiburi SK; Mwangi J; Maina G
    Addict Sci Clin Pract; 2022 Dec; 17(1):71. PubMed ID: 36510246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya.
    Ngarachu EW; Kiburi SK; Owiti FR; Kangethe R
    Subst Abuse Treat Prev Policy; 2022 Feb; 17(1):12. PubMed ID: 35168646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.